Sign in
4

Changes in Ownership

HERON THERAPEUTICS, INC. /DE/ Filed Acc 0000904454-13-000201

Options or other derivatives

  • SVP & Chief Medical Officer acquired 75,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Gelder Mark S. MD · SVP & Chief Medical Officer

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2013-02-08 Grant or award : show line 1 in the form Stock Option (right to buy) +75,000 $0.75 2023-02-08 75,000 75,000 D
Loading xslF345X03/edgar.xml…